Securing intellectual property is the heart of the Life Sciences Practice's commercialization strategy. This system includes the integration of downstream information, such as scientific data provided by contract research organizations (CROs) and contract manufacturing organizations (CMOs), into intellectual property strategies at the earliest stage. This enhances the potential for generating an increased revenue stream from licenses and investors. In addition, obtaining regulatory compliance can be advanced at an earlier stage by leveraging information from pre-clinical studies by the CROs and CMOs.

The diagram above illustrates the Life Sciences Practice's approach toward developing a commercialization strategy that leverages collaborator feedback, business model information, and other data, all of which are considered at each step in an integrated process. Using this system enhances our patent preparation and prosecution capabilities by incorporating downstream legal and business considerations into a patent application. For example, a patent application drafted to anticipate a potential licensee's product development and marketing strategies may enhance the value of the issued patent. Similarly, a patent application drafted to anticipate a future governmental regulatory focus may enhance the value of the issued patent. When additional commercialization guidance might be effective in enhancing the value of a patent, we have the resources to partner our clients with the appropriate network of outside experts.